The WGND conducts an annual survey of the global TB drugs pipeline, with the aim of increasing efficiency and coordination of the global TB drug R&D enterprise. A copy of the WGND global pipeline can be viewed via the enclosed link, which includes further details on the REMox clinical trials.

For additional publications relationg to the Tb drug pipeline, veiw the following links

New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future, March 2012, The Journal of Infectious Diseases

Current Status and Research Strategies in Tuberculosis Drug Development, August 2011, The Journal of Medicinal Chemistry

Global tuberculosis drug development pipeline: the need and the reality, June 2010, The Lancet